online casino singapore slot malaysia slot malaysia online casino singapore

Uniting Real-World
Ophthalmic Insights and
Proven Investment Experience

InFocus Capital Partners specializes in the identification, capitalization and development of breakthrough and disruptive opportunities in life sciences with an ophthalmic focus. The Fund’s experience, partnership structure and coverage of ophthalmic innovations yield a differentiated investment opportunity – optimizing the probability for successful returns.

Founders & Managing Principals

Robert Rothman

Rob Rothman, MD

Founding Partner & Principal

  • Twenty years of experience in venture capital deal sourcing, conducting diligence & funding
  • Member of the Board of Directors for Alievio, Cellview Imaging, Galimedix and QURA, Inc.
  • Clinical Assistant Professor of Ophthalmology at Hofstra Northwell School of Medicine & Past Director of Strategic Initiatives, Ophthalmology for the Northwell Health System
Ron Weiss

Ron Weiss, MD

Founding Partner & Principal

  • More than twenty years of experience in venture capital deal sourcing, structuring and investing. Co-founder of Prescient Capital Partners in 2001.
  • Founder of Chicago Eye Consultants, Chairman of Ophthalmology at MacNeal Hospital, and Assistant Professor of Ophthalmology at Rush University Medical Center. Medical Executive Committee and Chair of Finance Committee for Eyecare Services Partners.
  • Board of Directors for Cellview Imaging, ONL, 2C Tech, Re-Vana, Visibly, Infuse Spirits, Pinstripes and Chicago Children’s Choir

Portfolio Holdings

Advisory Board

Stuart Abelson

CEO & Managing Partner, Ora ADG, a division of Ora, Inc.

Robert L. Avery, MD

Founder, California Retina Consultants & California Retina Research Foundation

Matt Chapin

Senior Vice President, Asset Development & Partnering
Ora, Inc.

Aron Shapiro

Senior Vice President, Asset Development & Partnering
Ora, Inc.

Philip Ferrone, MD

Managing Partner & Director of Clinical Research at Long Island Vitreoretinal Consultants

Donald Fishbein

President, Evolve Therapeutics

David L. Katz, MD

Medical Advisor, PL Developments

Jeffrey M. Liebmann, MD

Vice-Chair, & Director of the Glaucoma Division of the Department of Ophthalmology at Columbia University Medical Center

Jodi Luchs, MD, FACS

InFocus Capital Partners Chief Science Advisor & Co-Medical Director, Eyevance Pharmaceuticals

Parag A. Majmudar, MD

President & Chief Medical Officer of Chicago Cornea Consultants, Ltd.

Steven I. Rosenfeld, MD, FACS

President, Delray Eye Associates, Executive Advisor, Blue Sea Capital & Chair of Ophthalmology, Modernizing Medicine

Jeffrey Smith

Chief Executive Officer & Chief Investment Officer of Starboard Value LP

Ira J. Udell, MD

Emeritus Chairman & Professor of Ophthalmology at the Zucker Hofstra Northwell School of Medicine

Charles C. Wykoff, MD, PhD

Director of Research at Retina Consultants of Houston & elected Deputy Chair of Ophthalmology for the Blanton Eye Institute


August 16, 2022

Visibly Becomes First FDA-Cleared Online Vision Test in the United States

Read More
March 30, 2022

Mojo Vision Reaches Significant Development Milestone for Smart Contact Lens

Read More
January 13, 2022

ONL Therapeutics Closes 2nd Tranche of $46.9 Million Series B Financing Upon Achieving ONL1204 Development Milestones

Read More